Treatment discontinuation in chronic myeloid leukemia: When, how, and why?

Fadi G. Haddad; Nicholas J. Short

doi:10.1002/ajh.27100

Treatment discontinuation in chronic myeloid leukemia: When, how, and why?

Fadi G. Haddad, Nicholas J. Short

Leukemia

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1670-1672
Number of pages	3
Journal	American journal of hematology
Volume	98
Issue number	11
DOIs	https://doi.org/10.1002/ajh.27100
State	Published - Nov 2023

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.27100

Cite this

@article{55fe58b343e74a189291daf7238f3444,

title = "Treatment discontinuation in chronic myeloid leukemia: When, how, and why?",

author = "Haddad, {Fadi G.} and Short, {Nicholas J.}",

year = "2023",

month = nov,

doi = "10.1002/ajh.27100",

language = "English (US)",

volume = "98",

pages = "1670--1672",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "11",

}

TY - JOUR

T1 - Treatment discontinuation in chronic myeloid leukemia

T2 - When, how, and why?

AU - Haddad, Fadi G.

AU - Short, Nicholas J.

PY - 2023/11

Y1 - 2023/11

UR - http://www.scopus.com/inward/record.url?scp=85172103208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85172103208&partnerID=8YFLogxK

U2 - 10.1002/ajh.27100

DO - 10.1002/ajh.27100

M3 - Editorial

C2 - 37753704

AN - SCOPUS:85172103208

SN - 0361-8609

VL - 98

SP - 1670

EP - 1672

JO - American journal of hematology

JF - American journal of hematology

IS - 11

ER -

Treatment discontinuation in chronic myeloid leukemia: When, how, and why?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this